Pharmaceuticals & Biotechnology | Pharma & Biotech Resources
Summary: Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community Through Pharma IQ, you will be able to access pharmaceutical information resources such as
- Visit Website
- RSS
- Artist: Unknown
Podcasts:
Lean principles drive cost reduction, improve efficiency and increase ROI. In this podcast, Elisabeth Goodman, former Business Operations Consultant, GlaxoSmithKline and Owner of RiverRhee Consulting, speaks to Andrea Charles at Pharma IQ, about the unique challenges to sustaining
In this interview Martin Jenkins, Senior Statistician at AstraZeneca, speaks to Andrea Charles from Pharma IQ, about exploring the potential uses of biomarkers to enhance early clinical development, a t which points they should be utilised and how. Jenkins draws attention to the
In this interview Jos van den Heuvel, Director of External Manufacturing at Janssen Pharmaceutica NV, Johnson & Johnson, speaks to Rebecca Maschke from Pharma IQ, about supplier integration and the advantages of establishing a data network collaboration.
Jim Thomson, Chair of the European Alliance for Access to Safer Medicines (EAASM), discusses the implications of the EU Pharma package with Helen Winsor from Pharma IQ. Thomson explains how pharmaceutical packaging and anti-counterfeiting measures have changed over the past five years.
It is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutical products are crystalline forms which, due to the intricacies of obviousness and
In this German-speaking interview, Jens Apermann, CEO of Iwan Budnikowsky Marketing GmbH, gives insight into his company’s marketing and selling of non-prescription pharmaceutical products outside the traditional German pharmacy setting.
When carried out well, adaptive trials not only provide evidence of safety and efficacy more quickly, but also allow you to assess that evidence and get answers earlier. In this interview John Johnson, Senior Biostatistician at Cato Research, speaks to Andrea Charles from
Patrice Talaga, Director of Chemistry Outsourcing at UCB, shares his experience of early alliance partnerships between academia and pharmaceutical companies, in this exclusive interview with Helen Winsor from Pharma IQ. Talaga outlines the main challenges in global discovery
20% of all clinical trials are now subject to regulatory audits! With inspectors’ expectations continually evolving and an increasing number of regulatory warnings, relating to record keeping and informed consent, it is more important than ever to comply with GCP and be
In this podcast Dr. Nair Rodriguez-Hornedo, Professor, Department of Pharmaceutical Sciences at the University of Michigan, s peaks to Andrea Charles from Pharma IQ, about h ow can we improve pharmaceuticals through co-crystals and overcoming the various challenges of co-crystal
In diesem Interview spricht Walter Heider, Director Commercial Department und Business Development bei der Sanofi-Aventis GmbH, über qualifizierte und zukunftsfähige Transportmöglichkeiten, und Herausforderungen in der Pharma Distribution.
You may have some or all of your informatics systems in place, and they may work well, but chances are good they do not work well together. Perhaps nowhere is this more noticeable than after mergers, when two or more firms need to be able to access and join previously separate data on
In this podcast Sven Knoke, Quality and Regulatory Affairs Manager at Siemens, speaks to Andrea Charles from Pharma IQ, about conducting effective clinical evaluations for medical devices and achieving market access by executing thorough clinical literature reviews.
In this interview Béatrice Serckx, Associate Director, Drug Production Industrial Strategy and CMO Management, UCB Pharma, speaks to Andrea Charles from Pharma IQ, about the hurdles to successful supplier integration and how to measure the success of your mitigation plan.
Shaul Brazil, a lawyer at BCL Burton Copeland, represented Robert John Dougall, the first executive to be prosecuted by the Serious Fraud Office (SFO) for overseas corruption. The case arose out of corrupt practices in the supply of orthopaedic products by Mr Dougall’s